Gitnux/Report 2026

Food and Drug Industry Statistics

The global pharmaceutical market reached $1.67 trillion in 2025, explore how GLP-1 demand and FDA activity shape growth, companies, and trends.
39Statistics
23Sources
4Sections
1Visuals
18mRead
Food and Drug Industry Statistics
How this report is researched
01Editorial Scope

An editor sets the topic, the inclusion criteria, and the evaluation framework before research starts.

02Source Research

AI search agents locate sources and extract each figure together with the document it came from.

Read our full methodology →

Search agents attach provenance to every extracted figure.

Next review: within 32 days

01 Industry overview

The food and drug industry at a glance

The combined food and drug economy spans a $2.51 trillion U.S. food retail and foodservice market in 2025 alongside a $1.67 trillion global pharmaceutical market, with demand shaped by convenience, chronic disease and price pressure.

$2.51T[5]
U.S. food sales, 2025
$1.67T[6]
Global pharma sales, 2025
1.77M[3]
U.S. food manufacturing jobs, 2026
54.8%[7]
North America pharma share, 2024
Market size
U.S. foodservice and food-retailing sales reached $2.51 trillion in inflation-adjusted 2025 dollars. Global pharmaceutical sales reached $1.67 trillion at ex-manufacturer prices in 2025.[5][6]
Forecast & CAGR
The global pharmaceutical market is forecast to grow at an 8.19% compound annual growth rate from 2026 through 2034, reaching $4.04 trillion by 2034. In U.S. food and beverage manufacturing, employment is projected to rise from 2.10 million in 2024 to 2.23 million in 2034, equivalent to roughly 0.6% annual growth.[8][3]
Market share & regions
North America accounted for 54.8% of global prescription-pharmaceutical sales in 2024, followed by Europe at 22.7%, China at 7.1% and Japan at 4.0%. In U.S. food spending, food away from home represented 56.3% of total food expenditures in 2025, versus 43.7% for food at home.[7][5]
Segmentation
U.S. food and beverage manufacturing employment in 2024 was concentrated in animal slaughtering and processing at 26%, bakeries and tortilla manufacturing at 17%, beverage manufacturing at 16% and other food manufacturing at 12%. Pharmaceutical demand is segmented across prescription medicines, with oncology among the largest therapeutic areas and GLP-1 medicines a major growth category in 2025.[3][9]
Key players & concentration
The pharmaceutical market is geographically concentrated: North America generated 54.8% of global prescription sales in 2024. Food manufacturing is more fragmented by product category; the largest U.S. employment segment, animal slaughtering and processing, represented 26% of food and beverage manufacturing employment in 2024.[7][3]
Pricing
Food pricing remains a major consumer issue: USDA reports that nominal food sales combine changes in prices with changes in purchased volume, so its 2025 estimate uses inflation-adjusted dollars. In European medicine pricing, manufacturers received an average 67.0% of retail price in 2023, while distributors, pharmacists and the state accounted for the remainder.[5][7]
Trends, drivers & challenges
Convenience is supporting food demand: U.S. limited-service food sales reached $516.1 billion in inflation-adjusted 2025 dollars, up 88.5% from 1997. Pharmaceutical growth is being driven by GLP-1 medicines, whose sales rose 46% to $75.8 billion in 2025, while patent expiries, biosimilars, affordability and supply-chain resilience remain challenges.[5][9]
Consumer behavior & competition
U.S. consumers allocated 56.3% of food expenditures to food away from home in 2025, indicating sustained demand for prepared meals and convenience. In pharmaceuticals, U.S. prescription sales reached $553 billion in 2025 and represented 46.5% of the global underlying market, reinforcing the country’s central role in competition.[5][9]
M&A
Food recorded 79 deals worth approximately $35 billion in 2025, compared with 92 deals worth about $67 billion in 2024; excluding the 2024 Mars–Kellanova transaction, 2025 food deal value increased nearly 70%. Ferrero’s approximately $3.1 billion acquisition of WK Kellogg was among the notable transactions.[10]
Regulation
FDA’s Center for Drug Evaluation and Research classified 321 drug recall events covering 755 products in 2025 and issued 314 warning letters. It also issued 970 drug-manufacturing inspection classification letters and more than 8,700 electronic certificates of pharmaceutical product.[4]
Latest news
Recent sector activity includes major packaged-food consolidation and continued portfolio reshaping: McCormick and Unilever announced a combination with approximately $20 billion in combined 2025 fiscal-year revenue, while 2025 food M&A also included Mars’ $35.9 billion acquisition of Kellanova.[11][12]

02 Ranking

Top 10 Companies in the Food And Drug Industry

The leading companies in the food and drug industry, ranked on market impact, performance, momentum, innovation and brand popularity.

Updated November 21, 2026 · Next review December 21, 2026

Verdict

Eli Lilly and Company stands out for diabetes and obesity treatments because it develops and manufactures major diabetes and obesity treatments, while Roche focuses on medicines paired with diagnostics since its R&D reached 19.8% of revenue in 2025.

Ranked by Overall score · How we score ↓

Editor's top 3 picks

Where to start, by need.

  1. #1 Overall · Leader in diabetes & obesity medicines

    Eli Lilly and Company

    US

    Ranked #1 · 9.5 · Diabetes & obesity medicines

    Why we picked it: Lilly develops and manufactures major diabetes and obesity treatments while funding R&D at an an R&D 20.5% of revenue share.

  2. Leader in pharmaceuticals & diagnostics

    Roche

    CH

    Ranked #2 · 9.0 · Pharmaceuticals & diagnostics

    Why we picked it: Roche combines innovative medicines with diagnostics, supported by an R&D spend of 19.8% of revenue.

  3. Leader in food ingredients & commodities

    Cargill

    US

    Ranked #3 · 8.9 · Food ingredients & commodities

    Why we picked it: Cargill supplies food, ingredients, and agricultural products across global supply chains, with reported revenue growth of 6.5%.

Pick 1 is the #1 company overall. Picks 2 and 3 are the highest-ranked companies in the top 5 that add a new segment.

Full ranking

Sort by
Top 10 companies in the food and drug industry, 2026 – Gitnux ranking
#CompanyOverall ↓Company snapshot
1

Eli Lilly and Company

Diabetes & obesity medicines · US

9.5
2

Roche

Pharmaceuticals & diagnostics · CH

9.0
3

Cargill

Food ingredients & commodities · US

8.9
4

Novo Nordisk

Diabetes & obesity medicines · DK

8.9
5

Novartis

Innovative prescription medicines · CH

8.9
6

AstraZeneca

Innovative prescription medicines · GB

8.8
7

Coca-Cola

Global non-alcoholic beverages · US

8.6
8

Unilever

Food, nutrition and consumer health products · GB

8.4
9

Nestlé

Global food, beverages, nutrition and petcare · CH

8.2
10

Sanofi

Vaccines and prescription medicines · FR

8.2

How we score

  • Impact (30%): scale and weight in the market (revenue, market share, employees, market position).
  • Performance (20%): recent revenue growth and operating margin; an analyst assessment where a company does not publish them.
  • Momentum (20%): growth trajectory and future potential.
  • Innovation (15%): R&D intensity and how technologically advanced the company is.

Popularity (brand search demand, 15%) counts toward Overall but is not published as a column. Overall leaves out what is not known.

Scale Scores are shown on a 7–10 scale with one decimal; bars start at 7.0.

Cadence Recalculated when new figures are published; next review December 21, 2026.

Independence. Rankings are editorially independent. Scores, ranks, picks and the verdict follow the method above; no company can pay to change them.

Cite this ranking

APA

Samuel Norberg. (2026, November 21). Top 10 companies in the food and drug industry. In Food And Drug Industry Statistics. Gitnux. https://gitnux.org/food-and-drug-industry-statistics/#top-companies

report visual · Comparison

Revenue of the largest food and drug companies

Cargill leads with $164.0B in annual revenue (group level, converted to USD).

Cargill$164.0B
Nestlé$101.1B
Roche$69.5B
Eli Lilly and Company$65.2B
AstraZeneca$58.7B
Unilever$54.5B
source-verifiedcargill.com · nestle.com · roche.com · investor.lilly.com · astrazeneca.com · unilever.com2026

04 Statistics

Market Intelligence

Market Intelligence ties scale and footprint to compliance and production capacity, including $1,039.2 billion in U.S. food manufacturing shipments in 2022 and $249.363 billion in U.S. pharmaceutical and medicine manufacturing employer sales in 2023.

Market size, volume and shipments in the food and drug industry

  • $1,039.2 billion in sales, value of shipments or revenue was reported for U.S. food manufacturing (NAICS 311) in 2022; the measure is monetary, not physical volume.[1]
  • $249.363 billion in employer sales, value of shipments or revenue was reported for U.S. pharmaceutical and medicine manufacturing (NAICS 32541) in 2023.[1]
  • 22.941 million tons of food-manufacturing exports were shipped from the United States in 2022, with an export shipment value of $35.886 billion; the two measures are weight and value.[2]

Forecast growth and shipments in the food and drug industry

  • Pharmaceutical-and-medicine-manufacturing output is projected to increase from $298.7 billion in 2025 to $400.7 billion in 2035, measured in chained 2017 dollars, with 3.0% annual output growth.[3]
  • Food-manufacturing employment is projected to rise from 1.783 million in 2025 to 1.867 million in 2035, an increase of 4.7%; BLS projects a 0.5% annual employment growth rate.[3]
  • Food-manufacturing output is projected to increase from $785.7 billion in 2025 to $951.1 billion in 2035, measured in chained 2017 dollars, with 1.9% annual output growth.[3]
  • Pharmaceutical-and-medicine-manufacturing employment is projected to rise from 355,400 in 2025 to 380,500 in 2035, an increase of 7.1%; BLS projects a 0.7% annual employment growth rate.[3]

Company counts and size structure in the food and drug industry

  • 24,888 firms and 29,780 establishments operated in U.S. food manufacturing (NAICS 311) in 2022.[1]
  • 1,436 employer establishments operated in U.S. pharmaceutical-preparation manufacturing (NAICS 325412) in 2023, a defined segment of pharmaceutical manufacturing.[1]
  • 2,905 employer establishments operated in U.S. pharmaceutical and medicine manufacturing (NAICS 3254) in 2023.[1]
  • 13,711 drug establishments were registered with FDA in fiscal year 2025, comprising 8,895 domestic and 4,816 foreign establishments.[4]

Regional split of the food and drug industry

  • 1,417 FDA-registered drug establishments were located in India in fiscal year 2025.[4]
  • 6,553 FDA-registered drug establishments were located in China in fiscal year 2025.[4]
  • 4,830 FDA-registered drug establishments were located in the European Union in fiscal year 2025.[4]

05 Statistics

Production & Operations

Production & Operations shows how cost, labor hours, and productivity moved in 2025 for U.S. NAICS 311, with unit labor costs rising 5.6% and productivity falling 2.1% measured as output per hour.

Productivity and capacity use in the food and drug industry

  • Food manufacturing unit labour costs rose 5.6% in 2025; U.S. NAICS 311.[3]
  • Food manufacturing hours worked increased 0.3% in 2025; U.S. NAICS 311.[3]
  • Food manufacturing labour productivity fell 2.1% in 2025, measured as output per hour; U.S. NAICS 311.[3]

06 Statistics

People & Workforce

People & Workforce quantifies staffing levels and wage context, including food manufacturing production and nonsupervisory employees averaging $24.63 per hour in September 2026.

Employment and hiring in the food and drug industry

  • Pharmaceutical and medicine manufacturing employment is projected to grow by 25,100 jobs between 2025 and 2035; U.S. NAICS 325400.[3]
  • Food manufacturing employment is projected to grow by 83,800 jobs between 2025 and 2035; U.S. NAICS 311000.[3]
  • Food manufacturing employed 1.783 million people in 2025, projected to reach 1.867 million by 2035, an increase of 4.7%; U.S. NAICS 311000.[3]
  • Pharmaceutical and medicine manufacturing employed 355,400 people in 2025, projected to reach 380,500 by 2035, an increase of 7.1%; U.S. NAICS 325400.[3]

Wages and labour costs in the food and drug industry

  • Food manufacturing production and nonsupervisory employees averaged $24.63 per hour in September 2026; U.S. NAICS 311.[3]
  • Food manufacturing employees averaged $28.93 per hour in September 2026; U.S. NAICS 311.[3]
  • Pharmaceutical and medicine manufacturing production and nonsupervisory employees averaged $29.69 per hour in August 2025; U.S. NAICS 3254.[3]

Workplace safety in the food and drug industry

  • Food manufacturing recorded 51 fatal occupational injuries in 2024; U.S. NAICS 311.[3]
  • Pharmaceutical and medicine manufacturing recorded 1.4 total recordable injury and illness cases per 100 full-time workers in 2024; U.S. NAICS 3254.[3]
  • Food manufacturing recorded 2.2 cases involving days away, job restriction or transfer per 100 full-time workers in 2025; U.S. NAICS 311.[3]
  • Food manufacturing recorded 3.1 total recordable injury and illness cases per 100 full-time workers in 2025; U.S. NAICS 311.[3]

07 Statistics

Regulation & Risk

Regulation & Risk highlights enforcement intensity, with FDA classifying 321 human-drug recall events covering 755 products in fiscal year 2025 and issuing 314 warning letters.

Regulations and compliance for food and drug

  • Infant-formula manufacturers require annual risk-based FDA inspections under the Food and Drug Omnibus Reform Act of 2022, U.S. jurisdiction; requirement currently in force.[4]
  • High-risk domestic food facilities must receive FDA inspections at least once every 3 years under the Food Safety Modernization Act, U.S. jurisdiction; requirement currently in force.[4]
  • Non-high-risk domestic food facilities must receive FDA inspections at least once every 5 years under the Food Safety Modernization Act, U.S. jurisdiction; requirement currently in force.[4]

Enforcement and penalties in the food and drug industry

  • 93 drug products were added to FDA import alerts in fiscal year 2025 to restrict potentially non-compliant products entering the U.S. supply chain.[4]
  • 87 arrests resulted from FDA criminal investigations in fiscal year 2024, with more than $2.5 billion in forfeitures, fines and restitutions across FDA-regulated food, drug and medical-product enforcement.[4]
  • 247 warning letters were issued to human-drug firms by FDA CDER in fiscal year 2025, covering U.S. drug compliance enforcement.[4]

Recalls and safety notices for food and drug

  • 321 human-drug recall events covering 755 recalled products were classified by FDA in fiscal year 2025 in the United States.[4]
  • 11 public-health advisories were issued from FDA CORE+EP investigations of FDA-regulated human foods in calendar year 2025 in the United States.[4]
  • 26 FDA CORE+EP investigations involving FDA-regulated human foods received response actions in calendar year 2025 in the United States.[4]
  • 69 FDA CORE+EP incidents involving FDA-regulated human foods were evaluated in calendar year 2025 in the United States, including outbreaks and adverse events.[4]
  • FDA-classified human-drug recalls in 2025 comprised 9% Class I, 80% Class II and 11% Class III recalled products in the United States.[4]

Key questions about the food and drug industry

What is the size of the food and drug economy in the United States and globally?
The combined food and drug economy spans a $2.51 trillion U.S. food retail and foodservice market in 2025 and a $1.67 trillion global pharmaceutical market in 2025.
How fast is the global pharmaceutical market growing through the end of the decade?
The global pharmaceutical market is forecast to grow at an 8.19% compound annual growth rate from 2026 through 2034, reaching $4.04 trillion by 2034.
Which companies lead the food and drug industry?
Eli Lilly and Company stands out for diabetes and obesity treatments because it develops and manufactures major diabetes and obesity treatments, while Roche focuses on medicines paired with diagnostics since its R&D reached 19.8% of revenue in 2025.
Which technology or product shifts are shaping demand in pharma and food?
GLP-1 medicines remain pharma’s growth engine, with sales rising 46% to $75.8 billion in 2025. In food, convenience is supporting demand, with U.S. limited-service food sales reaching $516.1 billion in 2025.
How concentrated is competition in pharmaceuticals versus food manufacturing?
North America generated 54.8% of global prescription sales in 2024. Food manufacturing is more fragmented by product category, where the largest U.S. employment segment, animal slaughtering and processing, represented 26% of food and beverage manufacturing employment in 2024.
What regulatory pressure shows up in FDA activity for drugs and foods?
In fiscal year 2025, FDA CDER issued 314 warning letters and classified 321 human-drug recall events covering 755 products. For foods, infant-formula manufacturers require annual risk-based FDA inspections, and high-risk domestic food facilities are inspected at least once every 3 years.
Reference

Cite This Report

This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.

APA
Samuel Norberg. (2026, November 21). Food And Drug Industry Statistics. Gitnux. https://gitnux.org/food-and-drug-industry-statistics
MLA
Samuel Norberg. "Food And Drug Industry Statistics." Gitnux, 21 Nov 2026, https://gitnux.org/food-and-drug-industry-statistics.
Chicago
Samuel Norberg. 2026. "Food And Drug Industry Statistics." Gitnux. https://gitnux.org/food-and-drug-industry-statistics.